KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Total Current Liabilities: 2015-2024

Historic Total Current Liabilities for BeOne Medicines (ONC) over the last 10 years, with Dec 2024 value amounting to $2.2 billion.

  • BeOne Medicines' Total Current Liabilities rose 16.94% to $2.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 billion, marking a year-over-year increase of 16.94%. This contributed to the annual value of $2.2 billion for FY2024, which is 22.36% up from last year.
  • BeOne Medicines' Total Current Liabilities amounted to $2.2 billion in FY2024, which was up 22.36% from $1.8 billion recorded in FY2023.
  • Over the past 5 years, BeOne Medicines' Total Current Liabilities peaked at $2.2 billion during FY2024, and registered a low of $917.4 million during FY2022.
  • Over the past 3 years, BeOne Medicines' median Total Current Liabilities value was $1.8 billion (recorded in 2023), while the average stood at $1.6 billion.
  • As far as peak fluctuations go, BeOne Medicines' Total Current Liabilities spiked by 246.49% in 2020, and later plummeted by 42.65% in 2022.
  • Yearly analysis of 5 years shows BeOne Medicines' Total Current Liabilities stood at $1.1 billion in 2020, then surged by 48.77% to $1.6 billion in 2021, then tumbled by 42.65% to $917.4 million in 2022, then skyrocketed by 97.32% to $1.8 billion in 2023, then increased by 22.36% to $2.2 billion in 2024.